CD4 and neoplasm: After tumor challenge in 4T1 model, also CD4+ cells were the dominant subtype, comprising around 56%, while in advanced tumors, CD8+ T cells rose to 35.86% (P=0.012), caused a reduction in CD4/CD8 ratio from 2:1 to 1.58:1 (Figure 3D).